Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2018 Jun 15;115(27):E6101–E6102. doi: 10.1073/pnas.1808882115

Reply to Agarwal: Activity against nuclear substrates is not necessarily mediated by nuclear Akt

Thomas A Leonard a,b,1
PMCID: PMC6142218  PMID: 29907610

The phosphorylation of Akt substrates in subcellular compartments other than the plasma membrane has previously been proposed to be mediated by the diffusion of activated Akt (1, 2). While this neatly accounts for the observation that Akt is activated by growth factors primarily at the plasma membrane, it poses problems for the cell in controlling the spatial and temporal dynamics of Akt substrate phosphorylation, since Akt would essentially be uncoupled from its activating stimulus. We recently showed that Akt activity is in fact confined to membranes enriched in either PI(3,4,5)P3 or PI(3,4)P2 (3, 4). By restricting Akt activity to the engagement of its activating lipid second messengers, both spatial and temporal control of Akt signaling is not lost. However, Agarwal (5) raises the question of how so-called “nuclear substrates” of Akt can be phosphorylated under these conditions. While more than 200 substrates of Akt have been identified, few have been carefully validated as bona fide Akt substrates and none that have been is exclusively nuclear. The FOXO family of transcription factors are, however, well-established Akt substrates, and insulin signaling via Akt2, in particular, leads to the termination of transcriptional programs for gluconeogenesis. Inactivation of Akt2 leads to insulin resistance and a severe form of inherited diabetes in humans (6). Phosphorylation of FOXO by Akt regulates its subcellular localization: unphosphorylated FOXO resides in the nucleus, where it drives transcription, while phosphorylated FOXO is sequestered in the cytoplasm by 14-3-3 proteins (7). The phosphorylation of FOXO by Akt may thus occur in the nucleus, thereby driving its nuclear export, or in the cytoplasm, thereby promoting its sequestration. Although early studies proposed the phosphorylation of FOXO by Akt in the nucleus (8), evidence for nuclear pools of PI(3,4,5)P3 or PI(3,4)P2 is lacking. This contrasts with the now-clear evidence for endomembrane pools of PI(3,4,5)P3 and PI(3,4)P2 that drive Akt signaling (3, 9). Furthermore, while Akt readily forms a complex with a model pseudosubstrate on endomembranes in the cytoplasm, we could not observe complex formation in the nucleus (3). Phosphorylation of a small pool of unphosphorylated FOXO in the cytoplasm and its sequestration by 14-3-3 proteins could drive nuclear exclusion simply by shifting the nucleo-cytoplasmic equilibrium. In general, the phosphorylation of substrates that are freely diffusible is entirely compatible with membrane-restricted Akt activity, while the phosphorylation of membrane-bound substrates such as TSC2 can be readily accounted for by the membrane trafficking of both PI(3,4,5)P3 and PI(3,4)P2, which results from the internalization of membrane receptors and their associated PI3K activity (10). In such cases, reactivation of Akt by PDK1 and mTOCR2 would not be necessary, since membrane-bound Akt is protected from dephosphorylation (4). Alternatively, Akt may be activated by phosphorylation on subcellular membranes distinct from the plasma membrane (9, 11). What is clear, however, is that phosphorylation of Akt alone does not relieve the steric occlusion of the substrate binding cleft mediated by its PH domain in the absence of PI(3,4,5)P3 or PI(3,4)P2 (4).

Footnotes

The author declares no conflict of interest.

References

  • 1.Kunkel MT, Ni Q, Tsien RY, Zhang J, Newton AC. Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J Biol Chem. 2005;280:5581–5587. doi: 10.1074/jbc.M411534200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Calleja V, et al. Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol. 2007;5:e95. doi: 10.1371/journal.pbio.0050095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ebner M, Lučić I, Leonard TA, Yudushkin I. PI(3,4,5)P3 engagement restricts akt activity to cellular membranes. Mol Cell. 2017;65:416–431.e6. doi: 10.1016/j.molcel.2016.12.028. [DOI] [PubMed] [Google Scholar]
  • 4.Lučić I, et al. Conformational sampling of membranes by Akt controls its activation and inactivation. Proc Natl Acad Sci USA. 2018;115:E3940–E3949. doi: 10.1073/pnas.1716109115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Agarwal AK. How to explain the AKT phosphorylation of downstream targets in the wake of recent findings. Proc Natl Acad Sci USA. 2018;115:E6099–E6100. doi: 10.1073/pnas.1808461115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.George S, et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004;304:1325–1328. doi: 10.1126/science.1096706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Brunet A, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857–868. doi: 10.1016/s0092-8674(00)80595-4. [DOI] [PubMed] [Google Scholar]
  • 8.Brunet A, et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol. 2002;156:817–828. doi: 10.1083/jcb.200112059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Braccini L, et al. PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling. Nat Commun. 2015;6:7400. doi: 10.1038/ncomms8400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Romanelli RJ, et al. Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. J Biol Chem. 2007;282:22513–22524. doi: 10.1074/jbc.M704309200. [DOI] [PubMed] [Google Scholar]
  • 11.Ebner M, Sinkovics B, Szczygieł M, Ribeiro DW, Yudushkin I. Localization of mTORC2 activity inside cells. J Cell Biol. 2017;216:343–353. doi: 10.1083/jcb.201610060. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES